Results 131 to 140 of about 1,535,241 (215)

THE CHEMOTHERAPY OF HELMINTHIASIS

Journal of Pharmacy and Pharmacology, 1958
openaire   +2 more sources

Metastatic prostate cancer with neuroendocrine differentiation and liver metastases: prognosis and response to platinum-based chemotherapy. [PDF]

World J Urol
Schaaf CW, von Amsberg G, Werner JJ, Mogler C, Borcherding N, Pfarr N, Steiger K, Jungmann F, Steinhelfer L, Lorenzini T, Schatz UA, Steinhaus J, Renders L, Heemann U, Gschwend J, Retz M, Jahnen M.   +16 more
europepmc   +1 more source

A biomarker analysis of plasma RIME and PD-L1 for stratifying first-line immunochemotherapy outcomes in advanced ESCC. [PDF]

iScience
Liu J, Ren RQ, He Y, Zhang QH, Zhang XM, Luo XJ, Cao YZ, Wu QN, Luo HY.   +8 more
europepmc   +1 more source

Intraperitoneal chemotherapy

Journal of British Surgery, 1944
openaire   +1 more source

Neoadjuvant Therapy for Non-Small Cell Lung Cancer: Recent Advances and Future Directions. [PDF]

Cancer Med
An H, Zhao J, Chen W, Li Y, Yan Y, Zhou C, Li R, Yao X, Dong X, Yang X, Hu Y, Chen J, Han C, Bai Y, Xu Y, Li Y.   +15 more
europepmc   +1 more source

Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy ± bevacizumab for recurrent or metastatic cervical cancer: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Luo R, Li M, Ma L, Huang Z.
europepmc   +1 more source

Salvage Chemotherapy After Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. [PDF]

In Vivo
Fushimi C, Okamoto I, Matsuki T, Okada T, Ueda Y, Takahashi H, Sato H, Kondo T, Tokashiki K, Hanyu K, Ito T, Kushihashi Y, Masubuchi T, Tada Y, Omura GO, Yamashita T, Oridate N, Tsukahara K.   +17 more
europepmc   +1 more source

Management of Patients Undergoing Chemotherapy in Conservative Dentistry. [PDF]

Cureus
Derras B, Bassim N.
europepmc   +1 more source